News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Alkermes Says in Deal to Sell Vivitrol in Russia
January 7, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Jan 7 (Reuters) - Biotechnology company Alkermes Inc (ALKS.O: Quote, Profile, Research) said it entered into an agreement to sell Vivitrol, a drug that treats alcohol and opioid dependence, in Russia and some other countries.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Earnings
‘Very Impressive’ Amvuttra ATTR-CM Sales Send Alnylam Soaring
August 1, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Merck’s $3B Savings Push Claims 6,000 Jobs
August 1, 2025
·
1 min read
·
Tristan Manalac
Earnings
Future of BMS’ Cobenfy Still in Limbo After Phase III Fail
July 31, 2025
·
2 min read
·
Tristan Manalac
Earnings
Sanofi Confident Tariffs Will Have Limited Impact on Finances in 2025
July 31, 2025
·
2 min read
·
Nick Paul Taylor
